Sodium butyrate, min. 98%, for synthesis, 25 g, plastic packaging.

2-(3-Chloro-phenoxy)-thiazole-4-carboxylic acid, 95.0%, 5g

5-Bromo-2-chloro-4,6-dimethylpyrimidine, 95.0%, 250mg

5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 1g

5-[3-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-amine, 95.0%, 2g

2-Fluoro-3-(trifluoromethyl)benzylamine, 97.0%, 1g

1,4,7-Trioxacyclotridecane-8,13-dione, 95.0%, 10mg

N-(Ethoxycarbonyl)-N-(furan-2-ylmethyl)glycine, 95%, 500mg

3-Iodo-1H-pyrrolo[2,3-b]pyridine>95.0%(GC)1g

[2-(Methylsulfanyl)-1,3-benzothiazol-6-yl]boronic acid, 98%, 250mg

4-(4-Chlorophenyl)-2-[(4-fluorobenzyl)amino]-4-oxobutyric acid, 10g

(2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol, 98.0%, 5g

Ethyl 2-Hydroxybutyrate>95.0%(GC)25g